Clinical Trials Browser

Phase 1/2 × Taxes × Tumor-Agnostic × Clear all

NCT06320405 2025-12-29

Axatilimab in Combination With Retifanlimab and Paclitaxel for the Treatment of Patients With Advanced or Metastatic Solid Tumors

Phase 1/2 Recruiting

Neoplasm Metastasis

NCT04652206 2021-12-29

PANTAX-Ib

Phase 1/2 Unknown

Neoplasms